Study of SHR-4298 for advanced solid tumors
Part of Cancer clinical trials.
This study tests a new drug called SHR-4298 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a type of advanced solid tumor that has come back or spread, and cannot be removed with surgery.
- You need to be in fairly good physical shape (able to do daily activities) and have a life expectancy of at least 3 months.
- You must have at least one tumor that can be measured on a scan.
- You need to provide a sample of your tumor tissue (from a previous or new biopsy) for testing.
- You should not have certain health issues, like active brain tumors, serious heart problems, or a weakened immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called SHR-4849 combined with other anticancer medications in people with advanced solid tumors. The goal is to see if this combination is safe and effective.
This trial is testing a new drug, SHR-7787, combined with other cancer treatments for people with advanced solid tumors that cannot be removed by surgery. The goal is to see if this combination can help shrink or control the cancer.
This trial tests a new drug called SHR-1826 for people with advanced solid tumors that have not responded to or are no longer helped by standard treatments. It is an early-phase study (Phase 1) to see if the drug is safe and how well it works.
This trial tests a new drug called SHR-4849 for people with advanced solid tumors that have not responded to other treatments. It aims to see if the drug is safe and effective, and may offer a new option for those who have limited choices.
This study tests a new experimental drug, SHR-4375, for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and effective for these cancers.
This trial tests a new drug called SHR-3792 for people with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to see if the drug is safe and how it affects the tumors.
Hear when a new Malignant Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.